...
首页> 外文期刊>Carcinogenesis >Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.
【24h】

Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.

机译:Six1促进人乳头瘤病毒16型永生化人角质形成细胞中的上皮-间质转化和恶性转化。

获取原文
获取原文并翻译 | 示例
           

摘要

Six1, a member of the Six family of homeodomain transcription factors, is overexpressed in various human cancers, and SIX1 overexpression is associated with tumor progression and metastasis. Six1 messenger RNA levels increase during in vitro progression of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes (HKc/HPV16) toward a differentiation-resistant (HKc/DR) phenotype. In this study, we show that HKc/DR-overexpressing Six1 exhibited a more mesenchymal phenotype, as characterized by a fibroblastic appearance and increased invasion. We utilized Whole Human Genome Microarrays to explore the gene expression changes associated with Six1 overexpression in HKc/DR. We found that overexpression of Six1 downregulated epithelial-related genes and upregulated mesenchymal-related genes, which suggests that Six1 overexpression induces epithelial-mesenchymal transition (EMT). Pathway analysis of the microarray data showed alterations in the transforming growth factor-beta (TGF-β) pathway, including enhanced expression of the TGF-β receptor type II (TβRII), and activation of the mitogen-activated protein kinase (MAPK) pathway in HKc/DR-overexpressing Six1, suggesting that Smad-independent pathways of TGF-β signaling may be involved in Six1-mediated EMT. p38 MAPK activation was required for sustained Six1-induced EMT and TβRII overexpression. Finally, we determined that Six1 overexpression in HKc/DR resulted in malignant conversion and increased the cancer stem cell (CSC)-like population. Thus, Six1 overexpression promotes EMT, CSCs properties and malignant conversion in HKc/DR through MAPK activation, which supports the possible use of p38-TβRII inhibitors for the treatment of cancers overexpressing Six1.
机译:Six1是同源域转录因子六族的成员,在各种人类癌症中均过表达,而SIX1的过表达与肿瘤的进展和转移有关。在人类乳头瘤病毒16型(HPV16)永生化的人类角质形成细胞(HKc / HPV16)向分化抗性(HKc / DR)表型的体外发展过程中,Six1 Messenger RNA水平升高。在这项研究中,我们显示过表达HKc / DR的Six1表现出更间质的表型,其特征是成纤维细胞的出现和侵袭的增加。我们利用全人类基因组微阵列来探索与HKc / DR中Six1过表达相关的基因表达变化。我们发现Six1的过表达下调上皮相关基因和间质相关的基因上调,这表明Six1的过表达诱导上皮-间质转化(EMT)。微阵列数据的途径分析显示了转化生长因子-β(TGF-β)途径的改变,包括TGF-βII型受体(TβRII)的表达增强以及促分裂原活化的蛋白激酶(MAPK)途径的激活在HKc / DR过表达的Six1中,提示TGF-β信号的Smad依赖性途径可能与Six1介导的EMT有关。持续的Six1诱导的EMT和TβRII过表达需要p38 MAPK激活。最后,我们确定HKc / DR中的Six1过表达导致恶性转化并增加了癌症干细胞(CSC)样的种群。因此,Six1过表达通过MAPK激活促进HKc / DR中的EMT,CSCs特性和恶性转化,这支持p38-TβRII抑制剂可能用于治疗过表达Six1的癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号